Table 4 Absolute and relative rate of ED among those ever prescribed urate-lowering therapy (ULT)
From: Gout and subsequent erectile dysfunction: a population-based cohort study from England
1-year landmark analysis Total patients = 9322 ULT exposed = 1249 | 3-year landmark analysis Total patients = 8650 ULT exposed = 1787 | |||||
|---|---|---|---|---|---|---|
Gout cases | ED events | Absolute rateb (95% CI) | Adjusted HR (95% CI)a | ED events | Absolute rateb (95% CI) | Adjusted HR (95% CI)a |
For overall ED reporting | ||||||
Not treated | 1364 | 194.8 (184.7–205.4) | 1.00 | 797 | 196.9 (184.9–209.6) | 1.00 |
Treated with ULT | 252 | 237.1 (209.6–268.3) | 1.14 (0.99–1.30) | 294 | 229.1 (204.4–256.9) | 1.07 (0.94–1.22) |
Pharmacologically treated ED | ||||||
Not treated | 797 | 113.8 (106.2–122.0) | 1.00 | 548 | 110.3 (101.5–120) | 1.00 |
Treated with ULT | 141 | 132.8 (112.5–156.5) | 1.12 (0.93–1.34) | 161 | 125.5 (107.5–146.4) | 1.08 (0.90–1.29) |